Jeremiah Degenhardt
VP Translational Computational Biology, Recursion
Jeremiah Degenhardt is listed as VP Translational Computational Biology, Recursion. Jeremiah is scheduled to speak at SLAS 2027 International Conference & Exhibition on 2 February 2027.
Compiled from published conference agendas; not yet confirmed by Jeremiah. Is this you? Claim this profile.
About
Jeremiah Degenhardt, PhD, is VP of Translational Computational Biology at Recursion, where he leads the development of integrated computational platforms for high-throughput target discovery and translational application. He co-leads efforts to unify phenomics, transcriptomics, and functional genomics data into scalable discovery workflows and drives the scientific approach to agentic AI development for automated drug discovery with emphasis on accuracy and reliability. With 16+ years of biotech experience, Jeremiah has deep expertise in assay development and optimization. At Maverick Therapeutics, as VP of Translational Oncology and Bioinformatics, he oversaw development and CRO transfer of PK/PD assays, designed FIH dose strategies, and managed critical translational data systems. At ImmuneID, he built bioinformatics and data science teams and developed AI/ML methods for systematic target discovery and screening. Jeremiah holds a PhD in Computational Biology with experience spanning